Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that recognizing specific histological features of different nonscarring alopecias is crucial for accurate diagnosis and understanding hair loss progression.

A man developed unusual growths after a hair transplant, which were treated successfully with no recurrence after a month.

Acne patients have higher levels of mTOR in their skin, which could be linked to future metabolic disease.

Topical L-thyroxine may help with wound healing and hair growth but should be used short-term due to potential risks.

More research is needed to find the best treatment for dissecting cellulitis of the scalp.

Effective treatment for hidradenitis suppurativa varies, with antibiotics commonly used and surgery as an option, but no single method is universally successful.

Microbes might play a role in vitiligo.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Premature graying of hair may suggest health issues and currently lacks effective treatments.

Topical tacrolimus did not regrow hair in alopecia universalis patients.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Nerves and chemicals in the body can affect hair growth and loss.

Vesiculobullous lesions should be considered part of canine cutaneous epitheliotropic T-cell lymphoma.

Topical vitamin D is effective in treating vitiligo with few side effects.

The document concludes that the understanding of scar formation is incomplete and current prevention and treatment for hypertrophic scars and keloids are not fully effective.

Cyclosporin A promotes hair growth in mice and increases a protein linked to hair growth, but it may not work the same way in humans.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Platelet lysate is a promising, cost-effective option for regenerative medicine with potential clinical applications.

Nd:YAG laser can reduce hair with multiple treatments, but permanent removal isn't guaranteed.

The monkey's hair loss was due to an autoimmune disease, not genetics.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Non-invasive methods can effectively diagnose and manage alopecia areata.

New hair and scalp disease diagnosis methods are important for correct treatment.

Stem-cell therapy shows promise for skin conditions but needs more research.

The skin's microbiome helps hair regrow by boosting certain cell signals and metabolism.

Extracellular vesicles show promise for treating psoriasis by reducing inflammation and skin lesions.

Botulinum Neurotoxin-A can treat acne, oily skin, rosacea, hair loss, prevent scars, relieve nerve pain, reduce excessive sweating, and manage psoriasis, but more trials are needed to confirm its effectiveness.

The protein p53 directly reduces the production of Keratin 17, a skin and hair protein, in rats with radiation dermatitis.